C. B. Verkleij

Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.

E. Bleecker, T. Casale, E. Bateman, 2015, The Lancet. Respiratory medicine.

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers

L. Bour, C. B. Verkleij, S. Horhota, 2015, The AAPS Journal.

Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety

E. Bleecker, T. Casale, E. Bateman, 2013 .

Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate

E. Bleecker, T. Casale, E. Bateman, 2013 .

Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses

E. Bleecker, T. Casale, E. Bateman, 2013 .

In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers

L. Bour, C. B. Verkleij, S. Horhota, 2015, The AAPS Journal.

Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials.

E. Bleecker, T. Casale, E. Bateman, 2015, The Lancet. Respiratory medicine.